Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Pier Paolo Quarato, Pozzilli, Italy – FDA Inspections
Company
•Italy

Pier Paolo Quarato, Pozzilli, Italy – FDA Inspections

Inspection records and compliance data for Pier Paolo Quarato in Pozzilli. 1 FDA inspection on record, last inspected April 03, 2015.

Sign in to open in Dashboard
Company Profile

This profile covers Pier Paolo Quarato based in Pozzilli, Italy.

FDA Inspection History

FDA inspections
1
OAI
0
VAI
0
NAI
1
Form 483s
0
Warning letters
0

Inspected April 3, 2015.

FDA inspections (1)

DateResultFDA center(s)Insp. #
April 3, 2015NAIHuman Drugs · Bioresearch Monitoring926867
FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Ruggero Capra, M.d.
Carmelo Rizzari, M.D.
Giovanni Di Perri, M.D.
Eugenio M. Mercuri, MD, PhD
SICOR Societa' Italiana Corticosteroidi s.r.l.
Valeria Santini, M.D.
Virginia Ferraresi
Neologistica S.R.L
Lorenzo Antonuzzo, M.D.
Anna Rita Ferrari
Company Information

Name

Pier Paolo Quarato

FEI Number

3011307248

Address

IRCS Instituto Neurologico Mediterraneo, Via Atinense 18, Pozzilli, Italy

Country

Italy

ID: 03d95bbd-7865-440c-b665-221304b98077

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.